What Has Been the Growth of the Primary Cell Culture Market So Far?
The primary cell culture market has seen considerable growth due to a variety of factors.
• The primary cell culture market has grown rapidly over the past few years. It is expected to expand from $6.79 billion in 2024 to $7.83 billion in 2025, achieving a compound annual growth rate (CAGR) of 15.2%.
The growth in the historical period can be attributed to the increased demand for monoclonal antibodies, the need for novel therapeutics, and the growing interest in personalized medicine and cell therapy research.
How Will the Primary Cell Culture Market?
The primary cell culture market is expected to maintain its strong growth trajectory in upcoming years.
• The primary cell culture market is projected to reach $13.65 billion by 2029, growing at a CAGR of 14.9%.
The growth drivers include the rise in cancer cases, expansion of pharmaceutical and biotech industries, demand for personalized medicine, and increased applications of 3D cell culture models. Key trends include technological advancements, product innovations, and strategic partnerships in R&D.
Which Factors Are Boosting Growth In The Primary Cell Culture Market?
The surge in chronic diseases is anticipated to drive the expansion of the primary cell culture market. Chronic diseases are enduring illnesses that usually progress gradually and persist for a long duration, frequently until the end of a person's life. The escalation in chronic diseases can be credited to a range of factors such as changes in lifestyle, environmental impact, lack of physical activity, alterations in diet, and demographic changes. Primary cell cultures play a crucial role in deepening our understanding and developing treatment solutions for chronic diseases, ultimately enhancing patient results. For example, in January 2023, the National Center For Biotechnology Information, a government agency in the US, projected a 99.5% increase in the number of individuals with at least one chronic disease, from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the escalating prevalance of chronic diseases is propelling the growth of the primary cell culture market.
What Key Areas Define The Segmentation Of The Global Primary Cell Culture Market?
The primary cell culture market covered in this report is segmented –
1) By Product: Primary Cell, Reagents, Supplements, Media
2) By Cell Type: Animal Cells, Human Cells
3) By Separation And culture Techniques: Explant Method, Enzymatic Disaggregation, Mechanical Separation, Other Separation
4) By Application: Tissue Culture and Tissue Engineering, Vaccine Production, Gene Therapy And Regenerative Medicine, Drug Screening And Toxicity Testing, Cancer Research, Virology, Strem Cell Therapy, Other Applications
5) By End User: Pharmaceutical And Biotechnology Company And Contract Research Organizations, Academic And Research Institutes, Other End Users
Subsegments:
1) By Primary Cell: Human Primary Cells, Animal Primary Cells
2) By Reagents: Enzymes, Buffers And Salts, Antibodies
3) By Supplements: Growth Factors, Serum Supplements, Hormones
4) By Media: Basal Media, Serum-Free Media, Specialty Media
Pre-Book The Primary Cell Culture Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Primary Cell Culture Market?
Key players in the primary cell culture market are pioneering the creation of cell banks dedicated solely to primary cells used for cultivated meat research, in a bid to propel advancements in ethical and sustainable meat production technologies. The goal of this Cell Bank project is to assist emerging businesses and researchers by offering top-notch animal primary cells, which are optimal for cultivated meat R&D. These are going to be up to 90% less costly compared to other providers of cell lines, and devoid of any licensing curbs. For instance, in June 2023, Extracellular, a CDMO (contract development and manufacturing organization) situated in the UK, introduced affordably priced, royalty-free cell banks to bolster the cultivated meat segment. Initially, these banks are slated to furnish cells extracted from fat, muscle, and bone marrow tissues of cows, pigs, and lambs. This initiative embodies a teamwork-based strategy aimed at boosting the expansion of the cultivated meat sector in the UK by ensuring better access to cell lines and facilitating businesses and researchers to create cutting-edge technologies free of any licensing or commercial contract limitations.
Who Are the Key Players In The Primary Cell Culture Market?
Major companies operating in the primary cell culture market are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• FUJIFILM Holdings Corporation
• GE HealthCare Technologies Inc.
• Corning Incorporated
• Lonza Group Ltd.
• Sartorius AG
• Miltenyi Biotec and CO.KG
• STEMCELL Technologies Inc.
• Cyagen Biosciences Inc.
• Hi Media Laboratories Pvt. Ltd.
• PromoCell GmbH
• AllCells LLC
• BPS Bioscience Inc.
• MatTek Ltd.
• Axol Bioscience Ltd.
• Lifeline Cell Technology Corp.
• Neuromics Inc.
• Cell Biologics Inc.
• ZenBio Inc.
• Epithelix Sàrl
• ReachBio LLC
• AcceGen Biotechnology
• Biopredic International
• ixCells Biotechnologies
What Is The Most Dominant Region In The Primary Cell Culture Market?
North America was the largest region in the primary cell culture market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary cell culture market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
